Bojan Vrtovec

Summary

Publications

  1. pmc Renal effects of levosimendan: a consensus report
    Mehmet B Yilmaz
    Department of Cardiology, Cumhuriyet University School of Medicine, Sivas, Turkey
    Cardiovasc Drugs Ther 27:581-90. 2013
  2. pmc Accuracy of advanced versus strictly conventional 12-lead ECG for detection and screening of coronary artery disease, left ventricular hypertrophy and left ventricular systolic dysfunction
    Todd T Schlegel
    Human Adaptation and Countermeasures Division, NASA Johnson Space Center, Houston, TX, USA
    BMC Cardiovasc Disord 10:28. 2010
  3. ncbi request reprint Effects of intracoronary stem cell transplantation in patients with dilated cardiomyopathy
    Bojan Vrtovec
    Advanced Heart Failure and Transplantation Center, Department of Cardiology, Ljubljana University Medical Center, Zaloska 7, Ljubljana, Slovenia
    J Card Fail 17:272-81. 2011
  4. ncbi request reprint Atorvastatin therapy may reduce the incidence of sudden cardiac death in patients with advanced chronic heart failure
    Bojan Vrtovec
    Advanced Heart Failure Center, Department of Cardiology, Ljubljana University Medical Center, Ljubljana, Slovenia
    J Card Fail 14:140-4. 2008
  5. ncbi request reprint Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up
    Bojan Vrtovec
    Advanced Heart Failure and Transplantation Center, Department of Cardiology, Ljubljana University Medical Center, Zaloska 7, Ljubljana, MC SI 1000, Slovenia
    Circ Res 112:165-73. 2013
  6. ncbi request reprint Comparison of transendocardial and intracoronary CD34+ cell transplantation in patients with nonischemic dilated cardiomyopathy
    Bojan Vrtovec
    Advanced Heart Failure and Transplantation Center B V, G P, Department of Nuclear Medicine L L, A s, and Department of Hematology M S, P C, University Medical Center Ljubljana, Ljubljana, Slovenia National Blood Transfusion Institute, Ljubljana, Slovenia D D Methodist DeBakey Heart Center, Houston, TX G T A Stanford Cardiovascular Institute F H, J C W and Department of Medicine, Division of Cardiology B V, F H, J C W, Stanford University School of Medicine, Stanford, CA
    Circulation 128:S42-9. 2013
  7. ncbi request reprint Atorvastatin therapy increases heart rate variability, decreases QT variability, and shortens QTc interval duration in patients with advanced chronic heart failure
    Bojan Vrtovec
    Division of Cardiology, Ljubljana University Medical Center, Ljubljana, Slovenia
    J Card Fail 11:684-90. 2005
  8. ncbi request reprint Relation of B-type natriuretic peptide level in heart failure to sudden cardiac death in patients with and without QT interval prolongation
    Bojan Vrtovec
    Advanced Heart Failure and Transplantation Center, Department of Cardiology, University Medical Center Ljubljana, Ljubljana, Slovenia
    Am J Cardiol 111:886-90. 2013
  9. pmc Stem cell therapy in patients with heart failure
    Bojan Vrtovec
    Ljubljana University Medical Center, Ljubljana, Slovenia
    Methodist Debakey Cardiovasc J 9:6-10. 2013
  10. ncbi request reprint Diabetes does not affect ventricular repolarization and sudden cardiac death risk in patients with dilated cardiomyopathy
    Bojan Vrtovec
    Advanced Heart Failure Center, Department of Cardiology, Ljubljana University Medical Center, Ljubljana, Slovenia
    Pacing Clin Electrophysiol 32:S146-50. 2009

Collaborators

  • Gregor Poglajen
  • Francois Haddad
  • Branislav Radovancevic
  • Vito Starc
  • Guillermo Torre-Amione
  • Todd T Schlegel
  • Gregor Zemljic
  • Matija Jelenc
  • Mehmet B Yilmaz
  • Katja Triller Vrtovec
  • Reynolds M Delgado
  • Rajko Radovancevic
  • Ivan Stojanovic
  • Matjaz Vrtovec
  • Veli Pekka Harjola
  • Sascha Treskatsch
  • Istvan Edes
  • John T Parissis
  • Mervyn Singer
  • Piero Pollesello
  • Julia Hasslacher
  • Sven Erik Ricksten
  • Alexandre Mebazaa
  • Jos le Noble
  • Matti Kivikko
  • Francesco Fedele
  • Sebastian Rehberg
  • Markku Salmenperä
  • Elena Grossini
  • José C Silva Cardoso
  • Luis M Rodríguez Fernández
  • Alexander Parkhomenko
  • Gerhard Wikstrom
  • Gerhard Poelzl
  • Ignacio Oulego Erroz
  • Andrea Morelli
  • Anders Oldner
  • Bojan Vrtotec
  • Nanthini Palanichamy
  • Alenka Briski
  • O H Frazier
  • Richard A Anderson
  • Aria P Yazdanbakhsh
  • Cynthia D Thomas
  • Andreja Kocijancic

Detail Information

Publications23

  1. pmc Renal effects of levosimendan: a consensus report
    Mehmet B Yilmaz
    Department of Cardiology, Cumhuriyet University School of Medicine, Sivas, Turkey
    Cardiovasc Drugs Ther 27:581-90. 2013
    ..As an example, a study is shortly to commence to assess the role of levosimendan for the prevention of acute organ dysfunction in sepsis (LeoPARDS). ..
  2. pmc Accuracy of advanced versus strictly conventional 12-lead ECG for detection and screening of coronary artery disease, left ventricular hypertrophy and left ventricular systolic dysfunction
    Todd T Schlegel
    Human Adaptation and Countermeasures Division, NASA Johnson Space Center, Houston, TX, USA
    BMC Cardiovasc Disord 10:28. 2010
    ..We hypothesized that a approximately 5-min resting 12-lead advanced ECG test ("A-ECG") that combined results from both the advanced and conventional ECG could more accurately screen for these conditions than strictly conventional ECG...
  3. ncbi request reprint Effects of intracoronary stem cell transplantation in patients with dilated cardiomyopathy
    Bojan Vrtovec
    Advanced Heart Failure and Transplantation Center, Department of Cardiology, Ljubljana University Medical Center, Zaloska 7, Ljubljana, Slovenia
    J Card Fail 17:272-81. 2011
    ..We investigated clinical effects of intracoronary transplantation of CD34+ cells in patients with dilated cardiomyopathy (DCM)...
  4. ncbi request reprint Atorvastatin therapy may reduce the incidence of sudden cardiac death in patients with advanced chronic heart failure
    Bojan Vrtovec
    Advanced Heart Failure Center, Department of Cardiology, Ljubljana University Medical Center, Ljubljana, Slovenia
    J Card Fail 14:140-4. 2008
    ..We sought to prospectively investigate a relation between atorvastatin therapy and SCD in patients with advanced chronic heart failure...
  5. ncbi request reprint Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up
    Bojan Vrtovec
    Advanced Heart Failure and Transplantation Center, Department of Cardiology, Ljubljana University Medical Center, Zaloska 7, Ljubljana, MC SI 1000, Slovenia
    Circ Res 112:165-73. 2013
    ..CD34+ transplantation in dilated cardiomyopathy was associated with short-term improvement in left ventricular ejection fraction and exercise tolerance...
  6. ncbi request reprint Comparison of transendocardial and intracoronary CD34+ cell transplantation in patients with nonischemic dilated cardiomyopathy
    Bojan Vrtovec
    Advanced Heart Failure and Transplantation Center B V, G P, Department of Nuclear Medicine L L, A s, and Department of Hematology M S, P C, University Medical Center Ljubljana, Ljubljana, Slovenia National Blood Transfusion Institute, Ljubljana, Slovenia D D Methodist DeBakey Heart Center, Houston, TX G T A Stanford Cardiovascular Institute F H, J C W and Department of Medicine, Division of Cardiology B V, F H, J C W, Stanford University School of Medicine, Stanford, CA
    Circulation 128:S42-9. 2013
    ..In an open-label blinded study, we compared intracoronary and transendocardial CD34(+) cell transplantation in patients with nonischemic dilated cardiomyopathy...
  7. ncbi request reprint Atorvastatin therapy increases heart rate variability, decreases QT variability, and shortens QTc interval duration in patients with advanced chronic heart failure
    Bojan Vrtovec
    Division of Cardiology, Ljubljana University Medical Center, Ljubljana, Slovenia
    J Card Fail 11:684-90. 2005
    ..Although statins decrease the incidence of ventricular arrhythmias in patients with atherosclerotic heart disease, their potential antiarrhythmic effects in heart failure remain undefined...
  8. ncbi request reprint Relation of B-type natriuretic peptide level in heart failure to sudden cardiac death in patients with and without QT interval prolongation
    Bojan Vrtovec
    Advanced Heart Failure and Transplantation Center, Department of Cardiology, University Medical Center Ljubljana, Ljubljana, Slovenia
    Am J Cardiol 111:886-90. 2013
    ..006), but BNP increase was not (p = 0.32). In conclusion, a BNP increase in patients with HF was associated with an increased risk of SCD only in patients with QTc interval prolongation...
  9. pmc Stem cell therapy in patients with heart failure
    Bojan Vrtovec
    Ljubljana University Medical Center, Ljubljana, Slovenia
    Methodist Debakey Cardiovasc J 9:6-10. 2013
    ..For these patients, stem cell therapies are being investigated as a safe treatment strategy for decreasing cardiac remodelling on top of conventional medical and device treatment...
  10. ncbi request reprint Diabetes does not affect ventricular repolarization and sudden cardiac death risk in patients with dilated cardiomyopathy
    Bojan Vrtovec
    Advanced Heart Failure Center, Department of Cardiology, Ljubljana University Medical Center, Ljubljana, Slovenia
    Pacing Clin Electrophysiol 32:S146-50. 2009
    ..We studied the effects of diabetes on ventricular repolarization parameters and sudden cardiac death in patients with dilated cardiomyopathy (DCM)...
  11. ncbi request reprint Commentary: is totipotency of a human cell a sufficient reason to exclude its patentability under the European law?
    Katja Triller Vrtovec
    Max Planck Institute for Intellectual Property, Competition and Tax Law, München, Germany
    Stem Cells 25:3026-8. 2007
    ..Disclosure of potential conflicts of interest is found at the end of this article...
  12. ncbi request reprint Trimetazidine shortens QTc interval in patients with ischemic heart failure
    Gregor Zemljic
    Advanced Heart Failure and Transplantation Center, Division of Cardiology, Ljubljana University Medical Center, Ljubljana, Slovenia
    J Cardiovasc Pharmacol Ther 15:31-6. 2010
    ..We analyzed the effects of trimetazidine on QTc interval in patients with ischemic heart failure...
  13. ncbi request reprint Chromium supplementation shortens QTc interval duration in patients with type 2 diabetes mellitus
    Matjaz Vrtovec
    Ljubljana University Medical Centre, Ljubljana, Slovenia
    Am Heart J 149:632-6. 2005
    ..We investigated the potential effects of chromium supplementation on QTc interval duration in type 2 diabetic patients...
  14. ncbi request reprint Levosimendan improves renal function in patients with advanced chronic heart failure awaiting cardiac transplantation
    Gregor Zemljic
    Advanced Heart Failure and Transplantation Center, Division of Cardiology, Ljubljana University Medical Center, Ljubljana, Slovenia
    J Card Fail 13:417-21. 2007
    ..Long-term impact of levosimendan on renal function remains undefined. Prospectively, we evaluated effects of levosimendan on renal function in patients with advanced chronic heart failure awaiting cardiac transplantation...
  15. ncbi request reprint Coronary artery disease alters ventricular repolarization dynamics in type 2 diabetes
    Bojan Vrtovec
    Division of Cardiology, Ljubljana University Medical Center, Ljubljana, Slovenia
    Pacing Clin Electrophysiol 28:S178-81. 2005
    ..18 +/- 7.45 ms versus 10.22 +/- 5.35 ms; P = 0.82). CAD increases VRD in patients with type 2 diabetes. Therefore, changes in ventricular repolarization in diabetic patients may be due to silent CAD rather than due to diabetes per se...
  16. ncbi request reprint Mitral regurgitation and axial flow left ventricular assist device: a computer simulation study
    Matija Jelenc
    Department of Cardiovascular Surgery, University Medical Centre Ljubljana, Ljubljana, Slovenia
    ASAIO J 59:405-9. 2013
    ..According to the computer model, LVAD support decreases mitral regurgitation. Furthermore, regurgitant volume has a smaller impact on the right ventricular afterload when compared with a heart without LVAD support. ..
  17. ncbi request reprint Outcomes in patients with low left ventricular ejection fraction after heart transplantation
    Branislav Radovancevic
    Cardiopulmonary Transplantation Service, Texas Heart Institute at St Luke s Episcopal Hospital, Houston, TX 77225 0345, USA
    Eur J Cardiothorac Surg 23:743-7. 2003
    ..We reviewed our database in order to determine outcomes in patients with low EF after HT and to identify a subset of patients who would benefit from immediate retransplantation...
  18. ncbi request reprint Factors predicting 10-year survival after heart transplantation
    Branislav Radovancevic
    Department of Cardiopulmonary Transplantation, Texas Heart Institute at St Luke s Episcopal Hospital, Houston, TX 77225, USA
    J Heart Lung Transplant 24:156-9. 2005
    ..We sought to identify factors predictive of long-term (>10-year) survival in heart transplant (HTx) recipients...
  19. ncbi request reprint End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices
    Branislav Radovancevic
    Center for Cardiac Support, Texas Heart Institute at St Luke s Episcopal Hospital, Houston, Texas 77225 0345, USA
    J Heart Lung Transplant 26:815-8. 2007
    ..Limited data exist about the long-term effects of continuous-flow vs pulsatile-flow left ventricular assist devices (LVADs) on end-organ function...
  20. ncbi request reprint Survival, graft atherosclerosis, and rejection incidence in heart transplant recipients treated with statins: 5-year follow-up
    Ivan Stojanovic
    Cardiopulmonary Transplantation Service, Texas Heart Institute at St Luke s Episcopal Hospital, Houston, Texas 77225 0345, USA
    J Heart Lung Transplant 24:1235-8. 2005
    ..Few studies have examined the long-term benefits of statin treatment in heart transplant recipients...
  21. ncbi request reprint Statin-associated QTc interval shortening as prognostic indicator in heart transplant recipients
    Bojan Vrtovec
    Department of Cardiac Transplantation, Texas Heart Institute at St Luke s Episcopal Hospital, Houston, Texas 77225 0345, USA
    J Heart Lung Transplant 25:234-6. 2006
    ..Statin-associated QTc shortening thus appears to be a favorable prognostic sign after transplantation...
  22. ncbi request reprint Brain natriuretic peptide levels and response to cardiac resynchronization therapy in heart failure patients
    Reynolds M Delgado
    Center for Cardiac Support, Texas Heart Institute at St Luke s Episcopal Hospital, Houston, TX 77225 0345, USA
    Congest Heart Fail 12:250-3. 2006
    ..046. A rise in BNP levels was associated with poor response (death or need for transplantation or left ventricular assist device and impaired long-term outcome), which makes it a good predictor to identify such patients...
  23. ncbi request reprint Prolonged QTc interval and high B-type natriuretic peptide levels together predict mortality in patients with advanced heart failure
    Bojan Vrtovec
    Heart Failure Center, Texas Heart Institute at St Luke s Episcopal Hospital, PO Box 20345, MC 2 114, Houston, Tex 77225 0345, USA
    Circulation 107:1764-9. 2003
    ..To better understand it, we analyzed the QTc interval duration in patients with heart failure with high B-type natriuretic peptide (BNP) levels and analyzed the combined prognostic impact of prolonged QTc and elevated BNP...